RIFADINE 300 mg, gélule, ANSATIPINE 150 mg, gélule clinical trials

RIFAMAB : Rifabutin versus rifampicin for treatment of staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy): a multicenter randomized, open-label, non-inferiority trial

This study compares two antibiotics, rifabutin and rifampicin, for treating joint infections caused by bacteria after surgery. It looks at how well they work to prevent further problems after a procedure called DAIR, which cleans the infection without removing the whole joint.